Non-Opioid Pain Treatment MarketNon-Opioid Pain Treatment Market By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen, Local Anesthetics, Antidepressants, Anticonvulsants, Corticosteroids and Others), By Application (Neuropathic Pain, Chronic Pain, Post-operative Pain and Acute Pain), By Route of Administration (Oral, Topical, Injectable and Other Route of Administration), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Published date: June 2025
Report ID: 151641
Number of Pages: 326
Format:

Fact Checked

Cite this Research

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
  - 1.8. Industry Voices
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    
    2.2.1. Drivers
    
    2.2.2. Restraints
    
    2.2.3. Opportunities
    
    2.2.4. Key Non-Opioid Pain Treatment Market Trends
  - 2.3. Application Landscape
  - 2.4. Regulatory Framework
  - 2.5. Sustainability and ESG (Environmental, Social, Governance)
  - 2.6. Opportunity Map Analysis
  - 2.7. Opportunity Orbits
  - 2.8. PESTLE Analysis
  - 2.9. PORTER’S Five Force Analysis
  - 2.10. Drivers & Restraints Impact Analysis
  - 2.11. Value Chain Analysis
    
    2.11.1. List of Raw Materials Suppliers
    
    2.11.2. List of Non-Opioid Pain Treatment Manufacturers
    
    2.11.3. List of Dealer/Distributors
  - 2.12. Regional Market Share and BPS Analysis
  - 2.13. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Non-Opioid Pain Treatment Market Analysis and Forecast, By Segment, 2020-2034
  - 3.1. Key Findings
  - 3.2. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 3.3. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
    
    3.3.1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    
    3.3.1.1. Insights
    
    3.3.1.2. Key Takeaways
    
    3.3.2. Acetaminophen
    
    3.3.2.1. Insights
    
    3.3.2.2. Key Takeaways
    
    3.3.3. Local Anesthetics
    
    3.3.3.1. Insights
    
    3.3.3.2. Key Takeaways
    
    3.3.4. Antidepressants
    
    3.3.4.1. Insights
    
    3.3.4.2. Key Takeaways
    
    3.3.5. Anticonvulsants
    
    3.3.5.1. Insights
    
    3.3.5.2. Key Takeaways
    
    3.3.6. Corticosteroids
    
    3.3.6.1. Insights
    
    3.3.6.2. Key Takeaways
    
    3.3.7. Others
    
    3.3.7.1. Insights
    
    3.3.7.2. Key Takeaways
  - 3.4. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 3.5. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
    
    3.5.1. Neuropathic Pain
    
    3.5.1.1. Insights
    
    3.5.1.2. Key Takeaways
    
    3.5.2. Chronic Pain
    
    3.5.2.1. Insights
    
    3.5.2.2. Key Takeaways
    
    3.5.3. Post-operative Pain
    
    3.5.3.1. Insights
    
    3.5.3.2. Key Takeaways
    
    3.5.4. Acute Pain
    
    3.5.4.1. Insights
    
    3.5.4.2. Key Takeaways
  - 3.6. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 3.7. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
    
    3.7.1. Oral
    
    3.7.1.1. Insights
    
    3.7.1.2. Key Takeaways
    
    3.7.2. Topical
    
    3.7.2.1. Insights
    
    3.7.2.2. Key Takeaways
    
    3.7.3. Injectable
    
    3.7.3.1. Insights
    
    3.7.3.2. Key Takeaways
    
    3.7.4. Other Route of Administration
    
    3.7.4.1. Insights
    
    3.7.4.2. Key Takeaways
  - 3.8. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 3.9. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
    
    3.9.1. Retail Pharmacies
    
    3.9.1.1. Insights
    
    3.9.1.2. Key Takeaways
    
    3.9.2. Hospital Pharmacies
    
    3.9.2.1. Insights
    
    3.9.2.2. Key Takeaways
    
    3.9.3. Online Pharmacies
    
    3.9.3.1. Insights
    
    3.9.3.2. Key Takeaways
- 4. Global Non-Opioid Pain Treatment Market Analysis and Forecast, By Region, 2020-2034
  - 4.1. Key Findings
  - 4.2. Global Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    
    4.2.1. North America
    
    4.2.1.1. Regional Insights
    
    4.2.2. Europe
    
    4.2.2.1. Regional Insights
    
    4.2.3. Asia Pacific
    
    4.2.3.1. Regional Insights
    
    4.2.4. Latin America
    
    4.2.4.1. Regional Insights
    
    4.2.5. Middle East & Africa
    
    4.2.5.1. Regional Insights
  - 4.3. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Region
- 5. North America Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
  - 5.1. Key Findings
  - 5.2. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 5.3. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - 5.4. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 5.5. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - 5.6. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 5.7. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - 5.8. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 5.9. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - 5.10. North America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 5.11. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
    
    5.11.1. The US
    
    5.11.2. Canada
- 6. Europe Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
  - 6.1. Key Findings
  - 6.2. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 6.3. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - 6.4. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 6.5. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - 6.6. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 6.7. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - 6.8. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 6.9. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - 6.10. Europe Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 6.11. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
    
    6.11.1. Germany
    
    6.11.2. The UK
    
    6.11.3. France
    
    6.11.4. Spain
    
    6.11.5. Italy
    
    6.11.6. Russia
    
    6.11.7. Netherland
    
    6.11.8. Rest of Europe
- 7. Asia Pacific Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
  - 7.1. Key Findings
  - 7.2. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 7.3. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - 7.4. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 7.5. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 7.7. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - 7.8. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 7.9. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - 7.10. Asia Pacific Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 7.11. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
    
    7.11.1. China
    
    7.11.2. Japan
    
    7.11.3. South Korea
    
    7.11.4. India
    
    7.11.5. Australia
    
    7.11.6. New Zealand
    
    7.11.7. Singapore
    
    7.11.8. Thailand
    
    7.11.9. Vietnam
    
    7.11.10. Rest of Asia Pacific
- 8. Latin America Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
  - 8.1. Key Findings
  - 8.2. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 8.3. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - 8.4. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 8.5. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - 8.6. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 8.7. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - 8.8. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 8.9. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - 8.10. Latin America Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 8.11. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
    
    8.11.1. Brazil
    
    8.11.2. Mexico
    
    8.11.3. Rest of Latin America
- 9. Middle East & Africa Non-Opioid Pain Treatment Market Analysis and Forecast, 2020-2034
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Drug Class, 2020-2034
  - 9.3. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - 9.4. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
  - 9.5. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  - 9.7. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - 9.8. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  - 9.9. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - 9.10. Middle East & Africa Non-Opioid Pain Treatment Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  - 9.11. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
    
    9.11.1. South Africa
    
    9.11.2. Saudi Arabia
    
    9.11.3. UAE
    
    9.11.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    
    10.7.1. Novartis AG
    
    10.7.1.1. Company Details
    
    10.7.1.2. Business Overview
    
    10.7.1.3. Product Portfolio
    
    10.7.1.4. Financial Insights
    
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.1.6. SWOT Analysis
    
    10.7.1.7. Geographic Footprint
    
    10.7.2. Teva Pharmaceutical Industries Ltd.
    
    10.7.2.1. Company Details
    
    10.7.2.2. Business Overview
    
    10.7.2.3. Product Portfolio
    
    10.7.2.4. Financial Insights
    
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.2.6. SWOT Analysis
    
    10.7.2.7. Geographic Footprint
    
    10.7.3. Dr. Reddy’s Laboratories Ltd.
    
    10.7.3.1. Company Details
    
    10.7.3.2. Business Overview
    
    10.7.3.3. Product Portfolio
    
    10.7.3.4. Financial Insights
    
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.3.6. SWOT Analysis
    
    10.7.3.7. Geographic Footprint
    
    10.7.4. Sun Pharmaceutical Industries Ltd.
    
    10.7.4.1. Company Details
    
    10.7.4.2. Business Overview
    
    10.7.4.3. Product Portfolio
    
    10.7.4.4. Financial Insights
    
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.4.6. SWOT Analysis
    
    10.7.4.7. Geographic Footprint
    
    10.7.5. GSK plc
    
    10.7.5.1. Company Details
    
    10.7.5.2. Business Overview
    
    10.7.5.3. Product Portfolio
    
    10.7.5.4. Financial Insights
    
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.5.6. SWOT Analysis
    
    10.7.5.7. Geographic Footprint
    
    10.7.6. Pfizer Inc.
    
    10.7.6.1. Company Details
    
    10.7.6.2. Business Overview
    
    10.7.6.3. Product Portfolio
    
    10.7.6.4. Financial Insights
    
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.6.6. SWOT Analysis
    
    10.7.6.7. Geographic Footprint
    
    10.7.7. Perrigo Company plc
    
    10.7.7.1. Company Details
    
    10.7.7.2. Business Overview
    
    10.7.7.3. Product Portfolio
    
    10.7.7.4. Financial Insights
    
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.7.6. SWOT Analysis
    
    10.7.7.7. Geographic Footprint
    
    10.7.8. Cipla Ltd.
    
    10.7.8.1. Company Details
    
    10.7.8.2. Business Overview
    
    10.7.8.3. Product Portfolio
    
    10.7.8.4. Financial Insights
    
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.8.6. SWOT Analysis
    
    10.7.8.7. Geographic Footprint
    
    10.7.9. Johnson & Johnson Services, Inc.
    
    10.7.9.1. Company Details
    
    10.7.9.2. Business Overview
    
    10.7.9.3. Product Portfolio
    
    10.7.9.4. Financial Insights
    
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.9.6. SWOT Analysis
    
    10.7.9.7. Geographic Footprint
    
    10.7.10. Pacira Pharmaceuticals, Inc.
    
    10.7.10.1. Company Details
    
    10.7.10.2. Business Overview
    
    10.7.10.3. Product Portfolio
    
    10.7.10.4. Financial Insights
    
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.10.6. SWOT Analysis
    
    10.7.10.7. Geographic Footprint
    
    10.7.11. Pierrel S.p.A.
    
    10.7.11.1. Company Details
    
    10.7.11.2. Business Overview
    
    10.7.11.3. Product Portfolio
    
    10.7.11.4. Financial Insights
    
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.11.6. SWOT Analysis
    
    10.7.11.7. Geographic Footprint
    
    10.7.12. Vertex Pharmaceuticals
    
    10.7.12.1. Company Details
    
    10.7.12.2. Business Overview
    
    10.7.12.3. Product Portfolio
    
    10.7.12.4. Financial Insights
    
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.12.6. SWOT Analysis
    
    10.7.12.7. Geographic Footprint
    
    10.7.13. Assertio Therapeutics
    
    10.7.13.1. Company Details
    
    10.7.13.2. Business Overview
    
    10.7.13.3. Product Portfolio
    
    10.7.13.4. Financial Insights
    
    10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.13.6. SWOT Analysis
    
    10.7.13.7. Geographic Footprint
    
    10.7.14. Mylan N.V. (Viatris)
    
    10.7.14.1. Company Details
    
    10.7.14.2. Business Overview
    
    10.7.14.3. Product Portfolio
    
    10.7.14.4. Financial Insights
    
    10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.14.6. SWOT Analysis
    
    10.7.14.7. Geographic Footprint
    
    10.7.15. Flexion Therapeutics
    
    10.7.15.1. Company Details
    
    10.7.15.2. Business Overview
    
    10.7.15.3. Product Portfolio
    
    10.7.15.4. Financial Insights
    
    10.7.15.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    
    10.7.15.6. SWOT Analysis
    
    10.7.15.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 2. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 3. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 4. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 5. Global Non-Opioid Pain Treatment Market Value (US$ Mn), By Region, 2020-2034
  - Table 6. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 7. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 8. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 9. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 10. North America Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
  - Table 11. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 12. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 13. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 14. The US Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 15. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 16. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 17. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 18. Canada Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 19. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 20. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 21. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 22. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 23. Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
  - Table 24. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 25. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 26. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 27. Germany Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 28. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 29. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 30. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 31. The UK Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 32. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 33. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 34. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 35. France Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 36. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 37. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 38. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 39. Spain Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 40. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 41. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 42. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 43. Italy Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 44. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 45. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 46. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 47. Russia Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 48. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 49. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 50. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 51. Netherland Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 52. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 53. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 54. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 55. Rest of Europe Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 56. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 57. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 58. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 59. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 60. Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
  - Table 61. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 62. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 63. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 64. China Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 65. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 66. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 67. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 68. India Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 69. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 70. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 71. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 72. Japan Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 73. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 74. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 75. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 76. South Korea Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 77. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 78. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 79. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 80. Australia Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 81. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 82. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 83. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 84. New Zealand Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 85. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 86. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 87. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 88. Singapore Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 89. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 90. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 91. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 92. Thailand Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 93. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 94. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 95. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 96. Vietnam Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 97. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 98. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 99. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 100. Rest of Asia Pacific Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 101. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 102. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 103. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 104. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 105. Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
  - Table 106. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 107. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 108. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 109. Brazil Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 110. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 111. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 112. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 113. Mexico Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 114. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 115. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 116. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 117. Rest of Latin America Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 118. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 119. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 120. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 121. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 122. Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Country, 2020-2034
  - Table 123. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 124. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 125. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 126. South Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 127. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 128. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 129. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 130. Saudi Arabia Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 131. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 132. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 133. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 134. UAE Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
  - Table 135. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Drug Class, 2020-2034
  - Table 136. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Application, 2020-2034
  - Table 137. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Route of Administration, 2020-2034
  - Table 138. Rest of Middle East & Africa Non-Opioid Pain Treatment Market Value (US$ Mn), By Distribution Channel, 2020-2034
- List of Figures
  - Figure 1. Global Non-Opioid Pain Treatment Market Snapshot: Market Value (US$ Mn), 2020-2034
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Non-Opioid Pain Treatment Market
  - Figure 5. Global Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 6. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - Figure 7. Global Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 8. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - Figure 9. Global Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 10. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - Figure 11. Global Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 12. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - Figure 13. Global Non-Opioid Pain Treatment Market Analysis, By Region, 2020, 2024 and 2034
  - Figure 14. Global Non-Opioid Pain Treatment Market Attractiveness Analysis, By Region
  - Figure 15. North America Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 16. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - Figure 17. North America Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
  - Figure 18. North America Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
  - Figure 19. North America Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
  - Figure 20. North America Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
  - Figure 21. North America Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
  - Figure 22. North America Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 23. North America Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
  - Figure 24. North America Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 25. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - Figure 26. North America Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
  - Figure 27. North America Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
  - Figure 28. North America Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
  - Figure 29. North America Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
  - Figure 30. North America Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 31. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - Figure 32. North America Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
  - Figure 33. North America Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
  - Figure 34. North America Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
  - Figure 35. North America Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
  - Figure 36. North America Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 37. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - Figure 38. North America Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
  - Figure 39. North America Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
  - Figure 40. North America Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
  - Figure 41. North America Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 42. North America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
  - Figure 43. Europe Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 44. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - Figure 45. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
  - Figure 46. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
  - Figure 47. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
  - Figure 48. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
  - Figure 49. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
  - Figure 50. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 51. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
  - Figure 52. Europe Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 53. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - Figure 54. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
  - Figure 55. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
  - Figure 56. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
  - Figure 57. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
  - Figure 58. Europe Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 59. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - Figure 60. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
  - Figure 61. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
  - Figure 62. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
  - Figure 63. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
  - Figure 64. Europe Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 65. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - Figure 66. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
  - Figure 67. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
  - Figure 68. Europe Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
  - Figure 69. Europe Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 70. Europe Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
  - Figure 71. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 72. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - Figure 73. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
  - Figure 74. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
  - Figure 75. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
  - Figure 76. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
  - Figure 77. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
  - Figure 78. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 79. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
  - Figure 80. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 81. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - Figure 82. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
  - Figure 83. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
  - Figure 84. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
  - Figure 85. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
  - Figure 86. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 87. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - Figure 88. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
  - Figure 89. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
  - Figure 90. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
  - Figure 91. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
  - Figure 92. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 93. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - Figure 94. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
  - Figure 95. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
  - Figure 96. Asia Pacific Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
  - Figure 97. Asia Pacific Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 98. Asia Pacific Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
  - Figure 99. Latin America Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 100. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - Figure 101. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
  - Figure 102. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
  - Figure 103. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
  - Figure 104. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
  - Figure 105. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
  - Figure 106. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 107. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
  - Figure 108. Latin America Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 109. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - Figure 110. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
  - Figure 111. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
  - Figure 112. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
  - Figure 113. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
  - Figure 114. Latin America Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 115. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - Figure 116. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
  - Figure 117. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
  - Figure 118. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
  - Figure 119. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
  - Figure 120. Latin America Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 121. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - Figure 122. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
  - Figure 123. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
  - Figure 124. Latin America Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
  - Figure 125. Latin America Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 126. Latin America Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
  - Figure 127. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Drug Class, 2020, 2024 and 2034
  - Figure 128. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Drug Class
  - Figure 129. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), 2020-2034
  - Figure 130. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Acetaminophen, 2020-2034
  - Figure 131. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Local Anesthetics, 2020-2034
  - Figure 132. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Antidepressants, 2020-2034
  - Figure 133. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Anticonvulsants, 2020-2034
  - Figure 134. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Corticosteroids, 2020-2034
  - Figure 135. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Others, 2020-2034
  - Figure 136. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Application, 2020, 2024 and 2034
  - Figure 137. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Application
  - Figure 138. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Neuropathic Pain, 2020-2034
  - Figure 139. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Chronic Pain, 2020-2034
  - Figure 140. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Post-operative Pain, 2020-2034
  - Figure 141. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Acute Pain, 2020-2034
  - Figure 142. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Route of Administration, 2020, 2024 and 2034
  - Figure 143. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Route of Administration
  - Figure 144. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Oral, 2020-2034
  - Figure 145. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Topical, 2020-2034
  - Figure 146. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Injectable, 2020-2034
  - Figure 147. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Other Route of Administration, 2020-2034
  - Figure 148. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Distribution Channel, 2020, 2024 and 2034
  - Figure 149. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Distribution Channel
  - Figure 150. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Retail Pharmacies, 2020-2034
  - Figure 151. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Hospital Pharmacies, 2020-2034
  - Figure 152. Middle East & Africa Non-Opioid Pain Treatment Market (US$ Mn), by Online Pharmacies, 2020-2034
  - Figure 153. Middle East & Africa Non-Opioid Pain Treatment Market Analysis, By Country, 2020, 2024 and 2034
  - Figure 154. Middle East & Africa Non-Opioid Pain Treatment Market Attractiveness Analysis, By Country
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Reddy’s Laboratories Ltd.
- Sun Pharmaceutical Industries Ltd.
- GSK plc
- Pfizer Inc.
- Perrigo Company plc
- Cipla Ltd.
- Johnson & Johnson Services, Inc.
- Pacira Pharmaceuticals, Inc.
- Pierrel S.p.A.
- Vertex Pharmaceuticals
- Assertio Therapeutics
- Mylan N.V. (Viatris)
- Flexion Therapeutics
- Other Key Players